Paricalcitol (Vials) 5µg/ml

Paricalcitol 5µg/ml vials support vitamin D metabolism and calcium balance in adults. Used as directed for secondary hyperparathyroidism in chronic kidney disease. Short-acting injectable form for clinical settings. Suitable for patients requiring precise vitamin D analog dosing.

Strength

5µg/ml

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Hexal

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Paricalcitol 5µg/ml vials are prescribed to manage secondary hyperparathyroidism in adults with chronic kidney disease. This injectable form helps regulate calcium levels and parathyroid hormone production when oral options are unsuitable. It is used under medical supervision in clinical environments.

Side Effects

Paricalcitol 5µg/ml vials work by mimicking natural vitamin D activity to reduce elevated parathyroid hormone levels. Patients may notice improved calcium balance over time with regular monitoring. Effects vary by individual and require professional oversight.

Precautions & Warnings

Store Paricalcitol 5µg/ml vials at room temperature away from light and moisture. Keep out of reach of children and pets. Inspect vials for particles or discoloration before use. Discard unused portions as directed by healthcare guidelines.

Avoid Interactions

Paricalcitol may interact with strong CYP3A inhibitors, thiazide diuretics, or calcium supplements. Alcohol and grapefruit products may alter metabolism. Inform your healthcare provider about all medications and supplements in use. Close monitoring is recommended during combined therapy.

Frequently Asked Questions

Paricalcitol is used to treat secondary hyperparathyroidism in adults with chronic kidney disease.

Paricalcitol 5µg/ml is given as an injection by healthcare professionals in a clinical setting.

Paricalcitol is available by prescription and may be purchased from licensed pharmacies with valid orders.

Paricalcitol is available in a 5µg/ml strength formulation in vials.

Common effects may include nausea or mild skin reactions; consult a healthcare provider for personalized advice.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.